Clinical epidemiology of cardiovascular disease in chronic renal disease.
Am J Kidney Dis. 1998; 32: S112-S119
Chronic kidney disease and mortality risk: a systematic review.
J Am Soc Nephrol. 2006; 17: 2034-2047
The clinical epidemiology of cardiac disease in chronic renal failure.
J Am Soc Nephrol. 1999; 10: 1606-1615
Beyond Framingham: cardiovascular risk profiling in ESRD.
J Am Soc Nephrol. 2005; 16: 1539-1541
Chronic kidney disease: effects on the cardiovascular system.
Circulation. 2007; 116: 85-97
Oxidative balance score and the risk of end-stage renal disease and cardiovascular disease.
Am J Nephrol. 2017; 45: 338-345
Association between redox status of serum albumin and peritoneal membrane transport properties in patients on peritoneal dialysis.
Blood Purif. 2015; 40: 243-249
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?.
Clin J Am Soc Nephrol. 2008; 3: 505-521
IL-6 levels, nutritional status, and mortality in prevalent hemodialysis patients.
Clin J Am Soc Nephrol. 2011; 6: 2253-2263
Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study.
Kidney Int. 1999; 55: 1945-1951
Oxidative stress and inflammation: implications in uremia and hemodialysis.
Clin Biochem. 2011; 44: 1189-1198
Cytokine secretion and markers of inflammation in relation to acidosis among chronic hemodialysis patients.
Blood Purif. 2013; 35: 181-186
Gut bacterial translocation may aggravate microinflammation in hemodialysis patients.
Dig Dis Sci. 2014; 59: 2109-2117
Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
Clin Sci (Lond). 2018; 132: 509-522
What would you like to eat, Mr CKD microbiota? A mediterranean diet, please! Kidney.
Blood Press Res. 2014; 39: 114-123
The kidney-gut Axis: implications for nutrition care.
J Ren Nutr. 2015; 25: 399-403
Chronic kidney disease alters intestinal microbial flora.
Kidney Int. 2013; 83: 308-315
Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD.
Am J Nephrol. 2014; 39: 230-237
The gastrointestinal tract in uremia.
Dig Dis Sci. 1993; 38: 257-268
Effect of chronic experimental renal insufficiency on urate metabolism.
J Am Soc Nephrol. 1995; 6: 1313-1317
Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation.
Nephrol Dial Transpl. 2012; 27: 2686-2693
Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction.
Am J Nephrol. 2013; 38: 99-103
Colonic transit time in long-term dialysis patients.
Am J Kidney Dis. 2004; 44: 322-327
Dietary iron supplementation: a proinflammatory attack on the intestine?.
Gut. 2015; 64: 696-697
Intestinal-renal syndrome: mirage or reality?.
Blood Purif. 2011; 31: 70-76
Meta-analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure.
PLoS One. 2015; 10: e0132589
p-Cresol and cardiovascular risk in mild-to-moderate kidney disease.
Clin J Am Soc Nephrol. 2010; 5: 1182-1189
Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients-A prospective cohort study.
Nephrol Dial Transpl. 2012; 27: 1169-1175
Probiotics and gastrointestinal health.
Am J Gastroenterol. 2000; 95: S2-S4
Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.
Hepatology. 2004; 39: 1441-1449
Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis.
J Hepatol. 2002; 37: 456-462
Beneficial effects of Bifidobacteria in a gastroresistant seamless capsule on hyperhomocysteinemia in hemodialysis patients.
J Ren Nutr. 2005; 15: 77-80
Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): a randomized trial.
Clin J Am Soc Nephrol. 2016; 11: 223-231
Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: a randomized clinical trial.
Nutr Metab Cardiovasc Dis. 2014; 24: 1043-1049
p-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis.
Korean J Pediatr. 2013; 56: 159-164
Probiotic supplementation in chronic kidney disease: a double-blind, randomized, placebo-controlled trial.
J Ren Nutr. 2018; 28: 28-36
Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: a randomized, controlled trial.
Mediators Inflamm. 2014; 2014: 348959
Application of bioimpedance spectroscopy in Asian dialysis patients (ABISAD): serial follow-up and dry weight evaluation.
Clin Kidney J. 2013; 6: 29-34
Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group.
J Am Soc Nephrol. 1996; 7: 198-207
The MOS 36-item short-form health survey (SF-36). I. Conceptual Framework and item Selection.
Med Care. 1992; 30: 473-483
SF-36 physical and mental health summary scales: a manual for users of version 1.
2nd ed. QualityMetric Incorporated,
Lincoln, RI2001: 2/3
Intestinal dysbiosis, barrier dysfunction, and bacterial translocation account for CKD-related systemic inflammation.
J Am Soc Nephrol. 2017; 28: 76-83
From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling.
Toxins (Basel). 2013; 5: 2042-2057
The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial.
Benef Microbes. 2015; 6: 423-430
Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects.
Kidney Int. 2017; 91: 435-442
The effects of probiotic supplement on hemoglobin in chronic renal failure patients under hemodialysis: a randomized clinical trial.
J Res Med Sci. 2017; 22: 74
Biotic supplements for renal patients: a systematic review and meta-analysis.
Nutrients. 2018; 10: 1224
Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status: a systematic review and meta-analysis of clinical trials.
Clin Nutr. 2020; 39: 789-819
Efficacy of probiotics supplementation on chronic kidney disease: a systematic review and meta-analysis.
Kidney Blood Press Res. 2018; 43: 1623-1635
Effects of probiotic supplementation on inflammatory biomarkers and uremic toxins in non-dialysis chronic kidney patients: a double-blind, randomized, placebo-controlled trial.
J Funct Foods. 2018; 46: 378-383
Effects of probiotics on inflammation and uremic toxins among patients on dialysis: a systematic review and meta-analysis.
Dig Dis Sci. 2019; 64: 469-479
Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patients.
Biomed Res Int. 2014; 2014: 568571
Correction to: an open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD).
Eur J Nutr. 2019; 58: 2157
Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.
Clin J Am Soc Nephrol. 2014; 9: 1603-1610
The influence of prebiotic arabinoxylan oligosaccharides on microbiota derived uremic retention solutes in patients with chronic kidney disease: a randomized controlled trial.
PLoS One. 2016; 11: e0153893
Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial.
Food Funct. 2018; 9: 6508-6516
Effect of Lactobacillus Rhamnosus on serum uremic toxins (phenol and P-Cresol) in hemodialysis patients: a double blind randomized clinical trial.
Clin Nutr ESPEN. 2018; 28: 158-164
Prebiotic, probiotic, and synbiotic supplementation in chronic kidney disease: a systematic review and meta-analysis.
J Ren Nutr. 2019; 29: 209-220
Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study.
Nephrol Dial Transpl. 2011; 26: 1094-1098
Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.
Nephrol Dial Transpl. 2019; 34: 1876-1884
Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis.
Front Med (Lausanne). 2018; 5: 124
Proportions of proinflammatory monocytes are important predictors of mortality risk in hemodialysis patients.
Mediators Inflamm. 2017; 2017: 1070959
End-stage renal disease, inflammation and cardiovascular outcomes.
Contrib Nephrol. 2017; 191: 32-43
Association of lipopolysaccharide-binding protein and coronary artery disease in men.
J Am Coll Cardiol. 2007; 50: 25-31
Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients.
Nephrology (Carlton). 2012; 17: 733-738
Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study.
Diabetol Metab Syndr. 2018; 10: 59
Serum lipopolysaccharide-binding protein is associated with chronic inflammation and metabolic syndrome in hemodialysis patients.
Blood Purif. 2019; 47: 28-36
High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease.
PLoS One. 2014; 9: e114881
Resistant starch alters the gut microbiota, uremic retention solutes and xeno-metabolite profiles concurrent with amelioration of chronic kidney disease in rats.
Am J Physiol Ren Physiol. 2016; 310: F857-F871
The salutary effect of amylose resistant starch (HAM-RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients.
Hemodialysis Int. 2018; 22: 492-500
Amylose resistant starch (HAM-RS2) supplementation increases the proportion of Faecalibacterium bacteria in end-stage renal disease patients: microbial analysis from a randomized placebo-controlled trial.
Hemodial Int. 2019; 23: 343-347